27510784|t|Application of BRAF V600E mutation - specific immunohistochemistry in diagnosis of gastrointestinal stromal tumors
27510784|a|To evaluate the utility of BRAF V600E allele - specific antibody in the diagnosis of gastrointestinal stromal tumors (GISTs). BRAF V600E mutation - specific immunohistochemistry and BRAF sequencing were performed in 24 consecutive GISTs, including 14 cases of KIT or PDGFRA mutations and 10 cases of KIT / PDGFRA wild GISTs. GISTs of 11 men and 13 women with a mean age 54 years(range 29-75 years) were included with tumors arising from stomach (16 cases), small bowel (7 cases), and peritoneal cavity (1 case). Strong and diffuse cytoplasmic BRAF staining was noted in 4 of 24 cases (17%), while 1 of 24 cases (4%) showed weak staining, and 19 of 24 cases (79%) had no staining. The four cases with strong BRAF immunostain were confirmed to have BRAF mutations, including 3 cases in the stomach and 1 case in the small intestine. All tumors showed spindle cell morphology. Only one case had progressive disease. No BRAF mutations were detected in cases with weak or negative BRAF immunostain. BRAF V600E mutation - specific immunohistochemistry is a highly sensitive and specific marker for detecting BRAF-mutated GISTs.
27510784	0	11	Application	T058	C0185125
27510784	15	25	BRAF V600E	T033	C3250916
27510784	26	34	mutation	T045	C0026882
27510784	37	45	specific	T080	C0205369
27510784	46	66	immunohistochemistry	T060	C0021044
27510784	70	79	diagnosis	T033	C0011900
27510784	83	114	gastrointestinal stromal tumors	T191	C0238198
27510784	118	126	evaluate	T058	C0220825
27510784	142	152	BRAF V600E	T033	C3250916
27510784	153	159	allele	T028	C0002085
27510784	162	170	specific	T080	C0205369
27510784	171	179	antibody	T116,T129	C0003241
27510784	187	196	diagnosis	T033	C0011900
27510784	200	231	gastrointestinal stromal tumors	T191	C0238198
27510784	233	238	GISTs	T191	C0238198
27510784	241	251	BRAF V600E	T033	C3250916
27510784	252	260	mutation	T045	C0026882
27510784	263	271	specific	T080	C0205369
27510784	272	292	immunohistochemistry	T060	C0021044
27510784	297	301	BRAF	T028	C0812241
27510784	302	312	sequencing	T169	C1561491
27510784	334	345	consecutive	T080	C1707491
27510784	346	351	GISTs	T191	C0238198
27510784	366	371	cases	T169	C0868928
27510784	375	378	KIT	T049	C1511353
27510784	382	398	PDGFRA mutations	T049	C1518782
27510784	406	411	cases	T169	C0868928
27510784	415	418	KIT	T028	C1416655
27510784	421	432	PDGFRA wild	T028	C1705319
27510784	433	438	GISTs	T191	C0238198
27510784	440	445	GISTs	T191	C0238198
27510784	452	455	men	T098	C0025266
27510784	463	468	women	T098	C0043210
27510784	476	480	mean	T081	C2347634
27510784	481	484	age	T032	C0001779
27510784	532	538	tumors	T191	C0027651
27510784	552	559	stomach	T023	C0038351
27510784	564	569	cases	T169	C0868928
27510784	572	583	small bowel	T023	C0021852
27510784	587	592	cases	T169	C0868928
27510784	599	616	peritoneal cavity	T030	C1704247
27510784	620	624	case	T169	C0868928
27510784	627	633	Strong	T080	C0442821
27510784	638	645	diffuse	T082	C0205219
27510784	646	657	cytoplasmic	T026	C0521449
27510784	658	662	BRAF	T116,T123	C1259929
27510784	663	671	staining	T033	C1704680
27510784	676	681	noted	T080	C4288581
27510784	693	698	cases	T169	C0868928
27510784	720	725	cases	T169	C0868928
27510784	738	742	weak	T080	C1762617
27510784	743	751	staining	T033	C1704680
27510784	766	771	cases	T169	C0868928
27510784	782	784	no	T169	C0332197
27510784	785	793	staining	T033	C1704680
27510784	804	809	cases	T169	C0868928
27510784	815	821	strong	T080	C0442821
27510784	822	826	BRAF	T116,T123	C1259929
27510784	827	838	immunostain	T130	C0038128
27510784	844	853	confirmed	T080	C0521093
27510784	862	876	BRAF mutations	T049	C1511021
27510784	890	895	cases	T169	C0868928
27510784	903	910	stomach	T023	C0038351
27510784	917	921	case	T169	C0868928
27510784	929	944	small intestine	T023	C0021852
27510784	950	956	tumors	T191	C0027651
27510784	964	976	spindle cell	T025	C0682540
27510784	977	987	morphology	T080	C0332437
27510784	998	1002	case	T169	C0868928
27510784	1007	1026	progressive disease	T047	C1335499
27510784	1028	1030	No	T169	C0332197
27510784	1031	1045	BRAF mutations	T049	C1511021
27510784	1051	1059	detected	T033	C0442726
27510784	1063	1068	cases	T169	C0868928
27510784	1074	1078	weak	T080	C1762617
27510784	1082	1090	negative	T033	C0205160
27510784	1091	1095	BRAF	T116,T123	C1259929
27510784	1096	1107	immunostain	T130	C0038128
27510784	1109	1119	BRAF V600E	T033	C3250916
27510784	1120	1128	mutation	T045	C0026882
27510784	1131	1139	specific	T080	C0205369
27510784	1140	1160	immunohistochemistry	T060	C0021044
27510784	1166	1182	highly sensitive	T080	C0439822
27510784	1187	1195	specific	T080	C0205369
27510784	1196	1202	marker	T201	C0005516
27510784	1207	1216	detecting	T033	C0442726
27510784	1217	1229	BRAF-mutated	T049	C1511021
27510784	1230	1235	GISTs	T191	C0238198